Cleveland Clinic 25th Annual Diabetes Therapeutics, Technology and Surgery 2021

Cleveland Clinic 25th Annual Diabetes Therapeutics, Technology and Surgery 2021

Regular price
$10.00
Sale price
$10.00
Regular price
Sold out
Unit price
per 

Cleveland Clinic 25th Annual Diabetes Therapeutics, Technology and Surgery 2021

Format:18 videos + 19 pdfs, size: 1.04 GB

Course Audience: primary care physicians, endocrinologists, diabetes educators

Overview:

Overview

The 25th annual Diabetes Day: Therapeutics, Technology and Surgery is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:

For over twenty five years, Cleveland Clinic has been at the forefront of diabetes treatment, research and education.  Its world class faculty has designed Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of management strategies and research on the complications of this disease.  It includes a detailed analysis of therapeutic options applicable to type 1 and type 2 diabetes, as well as their complications

Diabetes Day, Therapeutics, Technology and Surgery, is presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include a review of therapeutic options to manage both type 1 and 2 diabetes and the complications, including a pump update, dual hormone therapies, sulfonylureas, GLP1 agonists, metformin, and the role of exercise and fasting. New this year is a discussion of the pathophysiologic impact of COVID-19. The goal of this course is to increase practitioners’ competence and clinical performance to treat diabetes and its complications and, ultimately, to improve patient outcomes.

Attendees will be able to:

  • Describe the efficacy and side effects of therapeutic innovations for type 1 diabetes, including closed-loop insulin pumps, dual hormone therapy, and glucagon.
  • Compare the effectiveness of new and emerging therapies for both type 1 and 2 diabetes.
  • Critically appraise the impact of bariatric surgery on patients with type 2 diabetes.
  • Describe options for treating children with type 2 diabetes.
  • Compare the data on effectiveness of diets and exercise in diabetes strategies.
  • Summarize research defining the pathophysiologic impact of nonalcoholic steatohepatitis.
  • Describe how COVID-19 affects the progression of diabetes in infected patients

Who should attend?

This activity is designed for primary care physicians, endocrinologists, diabetes educators, pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who care for patients with diabetes.

 

Are Sulfonyureas Safe Focus on Carolina Trial (Video MP4 Format)

Are Sulfonyureas Safe Focus on Carolina Trial (PDF Format)

Cardiovascular Outcomes of Bariatric Surgery in Patients with Obesity and Diabetes (Video MP4 Format)

Cardiovascular Outcomes of Bariatric Surgery in Patients with Obesity and Diabetes (PDF Format)

Dawn of Glucagon (Video MP4 Format)

Dawn of Glucagon (PDF Format)

Diabetes and Lipids What Do the Guidelines Say (Video MP4 Format)

Diabetes and Lipids What Do the Guidelines Say (PDF Format)

Diabetes Management in Patients with COVID-19 (Video MP4 Format)

Diabetes Management in Patients with COVID-19 (PDF Format)

Do It Yourself (DIY) (Video MP4 Format)

Do It Yourself (DIY) (PDF Format)

Dual Hormone (Video MP4 Format)

Dual Hormone (PDF Format)

GLP-1 Agonists – Oral VS. SubQ (PDF Format)

Intermittent Fasting (Video MP4 Format)

Intermittent Fasting (PDF Format)

Management of Hypoglycemia Post Gastric Bypass (Video MP4 Format)

Management of Hypoglycemia Post Gastric Bypass (PDF Format)

Metformin Mechanism of Action – Role of Peptide YY, GLP-1 and GDF-15 (Video MP4 Format)

Metformin Mechanism of Action – Role of Peptide YY, GLP-1 and GDF-15 (PDF Format)

New Insulins (Video MP4 Format)

New Insulins (PDF Format)

New Treatment Options for Diabetes and the Kidney (Video MP4 Format)

New Treatment Options for Diabetes and the Kidney (PDF Format)

Pump Update-Hybrid Closed Loop (Control IQ, 780G, Horizon) (Video MP4 Format)

Pump Update-Hybrid Closed Loop (Control IQ, 780G, Horizon) (PDF Format)

Role of Exercise in Management of Diabetes (Video MP4 Format)

Role of Exercise in Management of Diabetes (PDF Format)

Should Metformin be First Line Therapy in Patients with DM2 and CAD (Video MP4 Format)

Should Metformin be First Line Therapy in Patients with DM2 and CAD (PDF Format)

Should NASH be Considered Part of the Metabolic Syndrome (Video MP4 Format)

Should NASH be Considered Part of the Metabolic Syndrome (PDF Format)

Surgical Management of Gastroparesis POP vs Pyloroplasty (Video MP4 Format)

Surgical Management of Gastroparesis POP vs Pyloroplasty (PDF Format)

Treatment of Type 2 Diabetes in Children (Video MP4 Format)

Treatment of Type 2 Diabetes in Children (PDF Format)